Cited by 104Iron Metabolism and DisordersNeurological diseases and metabolismTrace Elements in Health

The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.

Open access
Zohn, Irene E., De Domenico, Ivana, Pollock, Andrew, Ward, Diane McVey, Goodman, Jessica F., Liang, Xiayun, Sanchez, Amaru J., Niswander, Lee +1 more·2007·Blood

Abstract

Ferroportin disease is caused by mutation of one allele of the iron exporter ferroportin (Fpn/IREG1/Slc40a1/MTP1). All reported human mutations are missense mutations and heterozygous null mutations in mouse Fpn do not recapitulate the human disease. Here we describe the flatiron (ffe) mouse with a missense mutation (H32R) in Fpn that affects its localization and iron export activity. Similar to human patients with classic ferroportin disease, heterozygous ffe/+ mice present with iron loading of Kupffer cells, high serum ferritin, and low transferrin saturation. In macrophages isolated from ffe/+ heterozygous mice and through the use of Fpn plasmids with the ffe mutation, we show that Fpn(ffe) acts as a dominant negative, preventing wild-type Fpn from localizing on the cell surface and transporting iron. These results demonstrate that mutations in Fpn resulting in protein mislocalization act in a dominant-negative fashion to cause disease, and the Fpn(ffe) mouse represents the first mouse model of ferroportin disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2007-01-066068

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The flatiron (ffe) mouse model of human Ferroportin Disease harbors the FPNH32R mutation.

    “the flatiron (ffe) mouse model of human Ferroportin Disease, which harbors the FPNH32R mutation [36].”
  • A mouse model of the disease associated with loss-of-function ferroportin mutations, flatiron, was identified through a positional cloning effort.

    “Recently, a mouse model of the disease associated with loss-of-function ferroportin mutations, flatiron, was identified through a positional cloning effort.160”

    From Forging a field: the golden age of iron biology. (2008) · cites this paper as [160]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 104

Research works printed but not linked: 1

  1. Montosi G, Donovan A, Totaro A, et al. Autoso- mal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619-623.

Authors
Zohn, I. E., De Domenico, I., Pollock, A., Ward, D. M., Goodman, J. F., Liang, X., Sanchez, A. J., Niswander, L., & Kaplan, J.
Affiliations
  • Howard Hughes Medical Institute (US)
  • Department of Pathology, School of Medicine, University of Utah, Salt Lake City;
  • University of Utah (US)
  • Department of Pathology, University of Colorado Health Sciences Center, Denver
Venue
Blood
Published
2007-02-08
Volume
109
Issue
10
Pages
4174-4180
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2058180300
Cited by
104
References
25
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 3 · 2013: 6 · 2012: 4
FWCI
6.21
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Flatiron Health
  • National Institutes of Health
  • National Cancer Institute (T32CA8608604)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK070947)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32-HD08605)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords
ferroportin, ferroportin disease, dominant negative effect, missense mutations, iron export, protein mislocalization, Kupffer cells, serum ferritin, transferrin saturation, macrophages, mouse model, SLC40A1
MeSH terms
Ferroportin, Animals, Base Sequence, Cells, Cultured, DNA Mutational Analysis, Genes, Dominant, Humans, Iron, Macrophages, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Mutant Strains, Mutation, Iron Metabolism Disorders, Protein Transport, Cation Transport Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review